{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_19000", "batch_size": 200, "batch_pos": 64, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment factually describes a testing timeline without high-potency language.", "method": "llm_batch", "batch_id": "batch_2_15052", "batch_size": 200, "batch_pos": 49, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"hop_idx": 3, "answer": "uncertain", "rationale": "Missing response from batch", "method": "fallback", "batch_id": "batch_3_17364", "batch_size": 200, "batch_pos": 34, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment describes testing timelines, not realised impact with a moderate verb and scale.", "method": "llm_batch_retry", "retry": 1, "batch_id": "batch_3_17364_r1", "batch_size": 200, "batch_pos": 34, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"hop_idx": 4, "answer": "uncertain", "rationale": "Missing response from batch", "method": "fallback", "batch_id": "batch_4_13276", "batch_size": 200, "batch_pos": 33, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch_retry", "retry": 1, "batch_id": "batch_4_13276_r1", "batch_size": 200, "batch_pos": 33, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports a timeline for testing but contains no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_15268", "batch_size": 200, "batch_pos": 32, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "Segment does not contain a minimiser token paired with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_12928", "batch_size": 200, "batch_pos": 16, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_17612", "batch_size": 200, "batch_pos": 9, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes future activity/timeline for testing related to capability: 'late-stage testing would begin in 2025'.", "method": "llm_batch", "batch_id": "batch_8_7212", "batch_size": 200, "batch_pos": 154, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
